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Spinning skin into neurons
Basic helix-loop-helix proteins are transcriptional regulators with important
roles in myogenesis and neurogenesis. One such protein, NeuroD, has an
impressive ability to promote ectopic neuronal differentiation in Xenopus.
In the late 1980s, a remarkable convergence of discoveries
led to the identification of transcription factors in the
basic-helix-loop-helix (bHLH) family as critical cell-type
determinants in metazoans. Almost simultaneously,
bHLH proteins were uncovered by loss-of-function
mutations affecting the genesis of neurons in the fruitfly
[1], and by gain-of-function mutations affecting the gene-
sis of muscle in the mouse [2]. In addition, bHLH pro-
teins were identified in biochemical studies of mammalian
B-cell development. Together, these discoveries allowed
the formulation of a set of rules governing the interac-
tions of bHLH proteins in multimeric complexes [3]. As
the size of the bHLH family expanded, it became clear
that its diversity subserves two distinct developmental
functions: different bHLH proteins can act within a given
lineage to control successive stages in the development of
a particular cell type, and in different lineages to generate
distinct but related cell types [4]. Moreover, at a given
stage of development, bHLH proteins act in a genetic
network that involves both stimulatory and inhibitory
interactions between different family members [5].
The discovery that bHLH proteins are specifically
expressed in the developing vertebrate nervous system [6]
indicated that focusing on these proteins could lead to
useful insights into vertebrate, as well as invertebrate,
neurogenesis. Studies of bHLH protein functions in ver-
tebrate neurogenesis have lagged behind those of verte-
brate myogenesis, however, in part because of the
difficulty of obtaining both loss-of-function and gain-of-
function mutant phenotypes for a given gene within a
single vertebrate system. For example, targetted inactiva-
tion of the gene mammalian achaete-scute homolog 1
(Mash-1) in 'knockout' mice caused the elimination of
peripheral autonomic and olfactory sensory neurons [7],
but overexpression of Mash-1 has thus far not yielded
premature or ectopic neuronal differentiation in any
mammalian system [8]. On the other hand, overexpres-
sion of Xash-3, a Xenopus achaete-scute homolog normally
expressed at the time of neural induction [9], has been
shown to cause an expansion of neural tissue at the
expense of surrounding ectodermal tissue [10,11].
The recent description [12] of a striking gain-of-function
mutant phenotype of a novel bHLH gene, NeuroD, in
Xenopus has stirred interest in its product's function in ver-
tebrate neurogenesis. Importantly, although its name might
superficially suggest that NeuroD protein is a neural analog
of the myogenic determination factor MyoD, a compari-
son of the NeuroD gain-of-function phenotype to that of
Xash-3 suggests that NeuroD is more likely to play a role
in neuronal differentiation than in determination.
In contrast to Mash-1 and Xash-3, which were isolated by
using the polymerase chain reaction (PCR) to clone ver-
tebrate homologues of the Drosophila achaete-scute genes,
NeuroD was isolated by a genetic screen in yeast designed
to detect protein-protein interactions. This screen is
especially applicable to bHLH proteins, because they can
heterodimerize promiscuously with the ubiquitously-
expressed bHLH proteins of the 'E protein' subfamily,
such as E12/E47 or the product of the Drosophila daugh-
terless gene (an interaction partner of achaete-scute prod-
ucts) [3]. In both mouse and Xenopus, NeuroD mRNA is
transiently expressed by subsets of neurons just as they
begin to differentiate [12]. However, NeuroD is expressed
later than Mash-1 and Xash-3 in mouse and frog, respec-
tively (Fig. 1); for example, in the murine hindbrain,
Mash-1 is expressed in the ventricular zone whereas
NeuroD is not expressed until differentiating neuroblasts
have migrated out of the ventricular zone. These
descriptive data suggest that NeuroD functions at a later
stage in neurogenesis than do the the two vertebrate
achaete-scute homologues.
Three distinct phenotypes were observed in Xenopus
embryos in which NeuroD was overexpressed [12]. First,
a premature and more extensive differentiation of neu-
rons was observed in the central nervous system. Second,
a loss of non-neurogenic cephalic neural crest and an
expansion of neurogenic cephalic neural crest were
detected. Finally, an apparent conversion of non-neuro-
genic ectoderm to neurons was seen. Curiously, the tim-
ing of these effects was different: the neurogenic
phenotype within the neural plate was observed at stage
12, whereas that in the epidermis was not detected until
stage 19. This may reflect differences in the competence
of these tissues to respond to ectopic NeuroD expression,
as has been observed for ectopic achaete-scute expression
in Drosophila. Overexpression of NeulroD caused the gen-
esis of several different types of neuron, suggesting that it
participates in a common neuronal differentiation pro-
gram in several distinct neurogenic sublineages, rather
than in the specification of a specific neuronal cell type.
The NeturoD gain-of-function phenotype was distinct
from that of Xash-3 in two important respects: ectopic
Xaslh-3 caused an expansion of the neural plate at the
expense of surrounding ectoderm (Fig. 2a), whereas
ectopic NeuroD increased neuronal differentiation within
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Fig. 1. Expression of endogenous Xash-3
(blue) and NeuroD (green) mRNAs dur-
ing early Xenopus development.
Embryos at stage 12 express Xash-3 (a)
but not NeuroD (c) in the neural plate
(orange), whereas at stage 14 both
genes are expressed (b,d), albeit in dif-
ferent and apparently non-overlapping
patterns.
the neural plate but did not expand it (Fig. 2b). Con-
versely, ectopic NeuroD caused neuronal differentiation
within the epidermis (Fig. 2d), whereas ectopic Xash-3
did not (Fig. 2c). The neural plate data are consistent
with the idea that NeuroD can accelerate neuronal dif-
ferentiation in a cell population that is already deter-
mined. On the other hand, the ability of NeuroD to
induce neurogenesis in cultured animal caps as well as in
non-neurogenic ectoderm suggests that it can exert both
a determination and a differentiation function when
overexpressed. Nevertheless, the fact that NeuroD is
expressed later than Xash-3 leads Lee et al. [12] to con-
clude that NeuroD normally functions in differentiation
rather than determination.
Lee et al. [12] suggest that the reason NeuroD, but not
Xash-3, can generate ectopic neurons in the skin when
overexpressed may be because there are inhibitors of
bHLH activity in that tissue to which Xash-3, but not
NeuroD, is sensitive. The problem with this simple expla-
nation is that the ability of NeuroD to induce ectopic
neurons in the skin is restricted - only some of the skin
cells expressing ectopic NeuroD become neurons. Lee
et al. [12] suggest two possible explanations for this:
ectopic NeuroD may activate a lateral inhibition process
similar to that seen in Drosophila [13]; alternatively, neu-
ronal conversion may be restricted by some kind of a
prepattern in the skin, as indicated by the regularly-spaced
distribution of ciliated epidermal cells. Whatever the rea-
son, the action of NeuroD is clearly restricted in the skin,
and it will be important to understand the basis of this
restriction in order to define the activity of NeuroD.
Differential sensitivity of Xash-3 and NeuroD to
inhibitors, if real, could support a potentially important
distinction between 'determination' and 'differentiation'
bHLH proteins, previously suggested by Weintraub [5]
for myogenesis. Specifically, Weintraub proposed that
determination factors, such as myf5 and MyoD, are more
sensitive to inhibitory bHLH proteins, such as Id and
Hairy, than are differentiation factors, such as myogenin
and MRF4, because of structural differences between the
proteins [5]. A similar distinction might hold for Xash-3
and NeuroD [12]. The advantage of such a system is that
it permits control of determination by environmental
factors that regulate the inhibitors [13]. Once the deter-
mination bHLH proteins reached a critical threshold,
however, they might activate new bHLH proteins that
would be insensitive to the inhibitors, thereby 'locking'
the cell into a particular pathway of differentiation [5].
There are problems with applying this attractive model to
Xash-3 and NeuroD, though. Firstly, these two bHLH
proteins are not successively expressed in the same lineage,
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Fig. 2. Consequences of ectopic expres-
sion of Xash-3 and NeuroD in Xenopus
embryos, as assayed by expression of
the neural cell marker N-CAM (brown).
Embryos injected with either Xash-3
(a,c) or NeuroD (b,d) mRNA are illus-
trated at either stage 14 (a,b) or stage
24-26 (c,d). In (a,b), the injected side of
the embryo is to the right of the midline;
the left side serves as a control. Note
that Xash-3 overexpression expands the
neural tube (a), whereas NeuroD over-
expression widens the domain of N-
CAM expression within the neural tube,
but does not expand it (b). Conversely,
NeuroD overexpression -causes ectopic
N-CAM expression in subsets of ecto-
dermal cells (d), whereas Xash-3 over-
expression does not (c).
but rather in different regions of the nervous system
[9,12]. Their apparent differential sensitivities to inhibitors
might therefore reflect more the lineages in which they
are expressed than the stage of development that they
control. Secondly, the inability of NeuroD to expand the
neural plate could also be interpreted as reflecting a sensi-
tivity to inhibitors, although clearly these inhibitors would
have to be different than those operating in the skin.
In vertebrate myogenesis, there are at least four, and pos-
sibly five, different bHLH proteins that control sequential
steps of muscle development [14]. There is no reason to
think that neurogenesis should be any less complex.
Indeed, at least one additional bHLH protein, NSCL1,
appears to be expressed subsequent to NeuroD [15]. It
may be premature, therefore, to try to identify unitary
'determination' and 'differentiation' steps within a lin-
eage and assign them to specific bHLH proteins. Rather,
the process of commitment at the molecular level may be
a more gradual one, in which successively expressed
bHLH proteins progressively restrict the developmental
options of a precursor cell, perhaps by rendering it
increasingly insensitive to environmental influences that
could inhibit or alter its pathway of differentiation. In that
case, the different bHLH factors that operate in a given
lineage might be most usefully distinguished in terms of
their thresholds of sensitivity to various inhibitors.
The functional analysis of bHLH proteins has been com-
plicated by the fact that these proteins show both redun-
dancy and promiscuity. On the one hand, multiple,
redundant bHLH proteins may control a common devel-
opmental step; on the other hand, a single bHLH protein
may adopt the function of a related protein if misex-
pressed. Ideally, therefore, conclusions about the normal
function of a given bHLH protein should be based on
both loss-of-function and gain-of-function manipulations
within a given lineage, as has been possible in vertebrate
myogenesis and fly neurogenesis. Unfortunately, loss-of-
function genetic perturbations are presently difficult to
accomplish in Xenopus. Loss-of-function perturbations
for NeuroD are therefore most likely to be accomplished
in the mouse, the vertebrate system that is best suited for
gene disruption experiments.
Although the Xenopus data would lead one to predict that
targetted inactivation of the NeuroD gene should prevent
neuronal differentiation, an independent study [16] sug-
gests that NeuroD may function in other tissues as well.
Specifically, NeuroD was independently isolated in a yeast
interaction screen for bHLH proteins that bind to the
insulin promoter, where it was named BETA2 [16].
BETA2/NeuroD mRNA is expressed at high levels in
pancreatic 3 cell lines, and BETA2/NeuroD can function
as a strong transcriptional activator of the insulin pro-
moter-enhancer in transient co-transfection experiments
[16]. These results suggest that loss-of-function perturba-
tions of BETA2/NeuroD may affect the pancreatic islet
cells as well as the nervous system.
The study of bHLH proteins promises further oppor-
tunities to unravel the complex genetic circuitry that
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controls cell-type determination in general, and neuro-
genesis in particular. The discovery of NeuroD has iden-
tified an important new player that may control an
important late step in neuronal differentiation shared by
many classes of neurons, in many vertebrate (and possibly
invertebrate) organisms.
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